Now showing items 1-2 of 2

    • Combination therapy with oncolytic viruses and immune checkpoint inhibitors. 

      Chiu, M; Armstrong, EJL; Jennings, V; Foo, S; Crespo-Rodriguez, E; et al. (TAYLOR & FRANCIS LTD, 2020-06-02)
      Introduction: Immune checkpoint inhibitors (ICI) have dramatically improved the outcome for cancer patients across multiple tumor types. However the response rates to ICI monotherapy remain relatively low, in part due to ...
    • The effects of oncolytic Maraba virus (MG1) in advanced non-small cell lung cancer 

      McDonald, F; Chiu, M (Institute of Cancer Research (University Of London), 2021-08-31)
      Lung cancer is responsible for the highest cancer mortality worldwide. The prognosis for patients with advanced disease remains poor with five-year overall survival of <10%, highlighting the urgent unmet need for novel ...